Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms.

Cancer cell·2026

Same author

Assessing the contributions of noncoding RNAs in acute myeloid leukemia.

Blood neoplasia·2026

Same author

Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis.

bioRxiv : the preprint server for biology·2026

Same author

Loss of cystathionine-β-synthase contributes to elevated OXPHOS, a vulnerability in Ara-C-resistant Myeloid Leukemia in Down syndrome.

Biochemical pharmacology·2026

Same author

The GATA1 N terminus coordinates metabolic reprogramming in erythropoiesis.

Blood·2026

Same author

FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome.

The Journal of clinical investigation·2026

Search research articles

Related Experiment Video

Updated: Jan 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Acute Megakaryocytic Leukemia.

Maureen McNulty¹, John D Crispino¹

¹Northwestern University, Division of Hematology/Oncology, Chicago, Illinois 60611, USA.

Cold Spring Harbor Perspectives in Medicine

|September 25, 2019

Summary

Acute megakaryoblastic leukemia (AMKL) in children with Down syndrome (DS) presents unique genetic factors and a better prognosis. Understanding chromosome 21

Area of Science:

Hematology
Oncology
Genetics

Background:

Acute megakaryoblastic leukemia (AMKL) is a rare bone marrow malignancy affecting megakaryocytes.
Children with Down syndrome (DS) have a higher incidence of AMKL, with distinct clinical and genetic profiles.
AMKL in DS patients shows a different age of onset and improved prognosis compared to non-DS AMKL.

Purpose of the Study:

To discuss the role of chromosome 21 genes and other mutations in AMKL development.
To compare the clinical features of AMKL in Down syndrome (DS) and non-DS individuals.
To highlight the unique genetic landscape and prognostic factors in DS-AMKL.

Main Methods:

Review of existing literature on AMKL genetics and clinical presentations.
Comparative analysis of genetic mutations and clinical outcomes in DS-AMKL versus non-DS AMKL.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Isolation of Mouse Megakaryocyte Progenitors

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

Related Experiment Videos

Last Updated: Jan 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Isolation of Mouse Megakaryocyte Progenitors

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

Discussion of the functional implications of chromosome 21 genes in leukemia.

Main Results:

Specific genetic mutations contribute to AMKL pathogenesis, particularly in individuals with DS.
DS-AMKL exhibits distinct genetic mutations and a more favorable prognosis than non-DS AMKL.
Chromosome 21 genes play a significant role in the development and progression of AMKL.

Conclusions:

Understanding the genetic underpinnings of AMKL, especially those related to chromosome 21, is crucial.
Further research into chromosome 21 gene function may offer insights into other leukemia types.
Continued investigation into the molecular mechanisms of AMKL is needed for improved therapeutic strategies.